semaglutide for pets 40% of dog owners would consider 'Wagovy' their dog | Veterinary News Pet Safety Alert: Rising GLP-1

But the drug has been around longer than that.

Indication for obesity, mechanism, dosage, and medical-nutritional monitoring

Week-by-week results, timeline, and realistic expectations for safe fat loss.

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

Both have shown results in helping people lose

Patients with incomplete electronic documentation or with any history of invasive interventions were excluded from the study